Once seen as a promising antidepressant, psilocybin may pose risks in the perinatal period, with long-lasting effects observed in mice.

COOKIE-Pro precisely measures both the binding strength and reaction speed of drugs against thousands of potential targets simultaneously.

Revvity's new software product features intuitive co-registration tools and automated processes that reduce manual tasks and analysis time.

Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster the ...